Morgan Stanley Maintains Equal-Weight on Pfizer, Lowers Price Target to $55

Morgan Stanley analyst Matthew Harrison maintains Pfizer (NYSE:PFE) with a Equal-Weight and lowers the price target from $60 to $55.

Morgan Stanley analyst Matthew Harrison maintains Pfizer (NYSE:PFE) with a Equal-Weight and lowers the price target from $60 to $55.

Total
0
Shares
Related Posts